Manufacturer Tax Breaks For Patient Assistance Plans Targeted By AIDS Activists
Executive Summary
The AIDS Healthcare Foundation has put up billboards, placed sticker advertisements on newspapers, and held protests urging drug makers to lower the cost of HIV/AIDS medicines.
You may also be interested in...
Beware The Debt Deal’s Spending Cut Trigger: Medicare Part D And B Provider Pay Would Drop
Payments to Medicare providers will be cut if deficit reduction legislation drafted by a joint congressional committee is not enacted by Jan. 15, under the debt ceiling law President Obama signed Aug. 2.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.
Current Pathways For Rare Disease Drugs Are Not Optimal, US FDA’s Califf Says
Anticipating a ‘tsunami of therapies’ for rare diseases, commissioner says the agency will have to think of creative approaches and employ regulatory flexibility for them. FDA considers copying the oncology center’s Project Facilitate for expanded access to other diseases.